FBLN1 and Alzheimer disease: Experimental validation revealed that the FBLN1 gene expression in AD mice and normal group mice was the same as in the single-cell sequencing analysis, suggesting that hypomethylation of the FBLN1 gene may be involved in the mid-term pathological process of AD by promoting gene expression.